Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock

被引:39
作者
Fourrier, F
Jourdain, M
Tournoys, A
Gosset, P
Mangalaboyi, J
Chopin, C
机构
[1] Ctr Hosp Reg & Univ Lille, Hop Roger Salerno, Serv Reanimat Polyvalente, F-59037 Lille, France
[2] Ctr Hosp Reg & Univ Lille, Hop Roger Salerno, Equipe Rech JE2084, F-59037 Lille, France
[3] Ctr Hosp Reg & Univ Lille, Hop Roger Salerno, Hematol Lab B, F-59037 Lille, France
[4] Inst Pasteur, INSERM U416, F-59019 Lille, France
来源
SHOCK | 1998年 / 10卷 / 05期
关键词
D O I
10.1097/00024382-199811000-00010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Antithrombin III (ATIII) and protein C (PC) are major inhibitors of the coagulation cascade and might regulate the cytokine network. We tested the possibility that a combined supplementation using these two inhibitors might have synergistic effects on sepsis-induced disseminated intravascular coagulation and shock. Hemodynamics, coagulation parameters, tumor necrosis factor (TNF) alpha, and interleukin 6 levels were measured in pigs submitted to a bolus infusion of Escherichia coli endotoxin (lipopolysaccharide). Four groups were studied: control lipopolysaccharide, ATIII (100 IU/kg), PC (50 IU/kg), and ATIII-PC (same doses). The endotoxin infusion resulted in a typical hypokinetic shock with disseminated intravascular coagulation in all animals. Compared with the control group, a significant improvement in mean arterial pressure and systemic vascular resistance was observed in the PC and ATIII-PC groups. The increase in lactate levels was almost completely blunted in the PC group. A significant lesser increase in TNF alpha levels was observed in the ATIII-PC group. No effects were seen on interleukin 6 levels. Coagulation and fibrinolysis parameters were not improved by ATIII and/or PC, except for a lesser decrease in prothrombin time in the ATIII-PC group. We conclude that in this acute endotoxic model, a combined supplementation using PC and ATIII concentrates has favorable effects on hemodynamic parameters and TNF alpha levels, independently from the anticoagulant actions of these inhibitors.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 26 条
[1]  
BAUER KA, 1991, SEMIN HEMATOL, V28, P10
[2]   ACQUIRED ANTITHROMBIN-III DEFICIENCY - LABORATORY DIAGNOSIS, INCIDENCE, CLINICAL IMPLICATIONS, AND TREATMENT WITH ANTITHROMBIN-III CONCENTRATE [J].
BULLER, HR ;
TENCATE, JW .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3B) :S44-S48
[3]  
DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98
[4]  
DICKNEITE G, 1997, INTENSIVE CARE ME S1, V23, pS58
[5]   EFFICACY OF ANTITHROMBIN-III SUPPLEMENTATION IN ANIMAL-MODELS OF FULMINANT ESCHERICHIA-COLI ENDOTOXEMIA OR BACTEREMIA [J].
EMERSON, TE ;
FOURNEL, MA ;
REDENS, TB ;
TAYLOR, FB .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3B) :S27-S33
[6]  
Esmon CT, 1997, THROMB HAEMOSTASIS, V78, P70
[7]   SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES [J].
FOURRIER, F ;
CHOPIN, C ;
GOUDEMAND, J ;
HENDRYCX, S ;
CARON, C ;
RIME, A ;
MAREY, A ;
LESTAVEL, P .
CHEST, 1992, 101 (03) :816-823
[8]   DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTITHROMBIN-III CONCENTRATES IN SEPTIC SHOCK WITH DISSEMINATED INTRAVASCULAR COAGULATION [J].
FOURRIER, F ;
CHOPIN, C ;
HUART, JJ ;
RUNGE, I ;
CARON, C ;
GOUDEMAND, J .
CHEST, 1993, 104 (03) :882-888
[9]  
FOURRIER F, 1990, INTENS CARE MED, V16, P1
[10]  
Gray E, 1996, HAEMOSTASIS, V26, P92